Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine plus butorphanol for burn dressing change analgesia and sedation
ChiCTR2300071821Phase 4Not yet recruiting
- Sponsor
- Jiangsu University Affiliated Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and butorphanol in burn injury (2 arms), sponsored by Jiangsu University Affiliated Hospital. Primary endpoints: Sedation score and Pain score. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR2300071821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071821.